TheraSource is a growing biotech company located in the Greater New York area. Our mission is to develop novel anti-inflammatory therapeutics for the treatment of human diseases. TheraSource is currently focused on the development of newly-discovered molecules to treat patients with ischemic acute kidney injury (AKI) and acute radiation injury. TheraSource's R&D unit resides at The Feinstein Institute for Medical Research, which is equipped with a state-of-the-art preclinical testing facility. Our research team currently consists of 9 scientists with MD or PhD degrees in multidisciplinary areas, including protein chemistry, cell biology, immunology, pathophysiology, and clinical medicine. The company possesses 14 utility patents covering 5 molecules to treat selected inflammatory human diseases.
Looking for a particular TheraSource, LLLC employee's phone or email?
The TheraSource, LLLC annual revenue was $5 million in 2026.
2 people are employed at TheraSource, LLLC.
TheraSource, LLLC is based in Roslyn, New York.
The NAICS codes for TheraSource, LLLC are [5619, 56, 561, 56199, 561990].
The SIC codes for TheraSource, LLLC are [73, 738].